I guess we should add OPK's CEO is very old. CEO Phillip Frost is one of the wealthiest people in the world at 84 years old. After 13 years as Chairman and CEO of OPKO, it's possible that Frost could take advantage of the timing and exit the business through a sale to begin his retirement this year. And I saw that little blurb that they were highlighted in some newsletter that had a name that made me think of M&A & I put 2 and 2 togteher (always dangerous) and said
Damn This Cat is going to SELL-!!!
That Bio rad division must be worth a lot more than he paid for it.... OR
VICEY VERSE""""""
Choice A)They could sell Bio Rad to the highest bidder!
When OPKO purchased BioReference Labs
for $1.47 billion in 2015, the former had only $91 million in annual revenue compared to
$832 million for the company it bought.
Alright they paid a lot granted.... But Now TESTING IS WAY HIGHER AT Bio-Rad
Choice B) OPKO might sell its pharmaceutical assets and complete the transformation into solely a diagnostics business.<----?
2 choices.... )))) Could some inkling of this come out at the
39th Annual J.P. Morgan Healthcare Conference-
OPKO Health, Inc. (NASDAQ: OPK announced that management will be participating in the 39thAnnual J.P. Morgan Healthcare Conference being held virtually on January 11-14, 2021. Management will be hosting one-on-one meetings with investors and
will be presenting on Wednesday, January 13that 3:40 p.m. Eastern time.
OPK $4.50 Now Target $6.50+